Sonova Holding AG (SWX:SOON)

Revenue

Financials in millions CHF. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013
Hearing Instruments Business Revenue	1.83B	1.82B	1.70B
Hearing Instruments Business Revenue Growth	0.64%	7.29%	-6.17%
Audiological Care Business Revenue	1.49B	1.49B	1.41B
Audiological Care Business Revenue Growth	0.38%	5.46%	3.88%
Consumer Hearing Business Revenue	232.60M	252.50M	239.70M
Consumer Hearing Business Revenue Growth	-7.88%	5.34%	-15.69%
Total Hearing Instruments Segment Revenue	3.56B	3.56B	3.35B
Total Hearing Instruments Segment Revenue Growth	-0.07%	6.38%	-3.00%
Cochlear Implant Systems Revenue	202.60M	214.90M	185.50M
Cochlear Implant Systems Revenue Growth	-5.72%	15.85%	0.05%
Upgrades and Accessories Revenue	85.90M	89.00M	93.40M
Upgrades and Accessories Revenue Growth	-3.48%	-4.71%	-7.98%
Total Cochlear Implants Segment Revenue	288.50M	303.90M	278.90M
Total Cochlear Implants Segment Revenue Growth	-5.07%	8.96%	-2.79%

Revenue by Geography

Financials in millions CHF. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013
Switzerland Revenue	29.80M	30.60M
Switzerland Revenue Growth	-2.61%	-14.76%
EMEA (excl. Switzerland) Revenue	1.94B	1.83B
EMEA (excl. Switzerland) Revenue Growth	6.29%	-0.21%
USA Revenue	1.16B	1.07B
USA Revenue Growth	7.71%	-6.61%
Americas (excl. USA) Revenue	278.90M	264.40M
Americas (excl. USA) Revenue Growth	5.48%	-3.50%
Asia/Pacific Revenue	456.40M	429.40M
Asia/Pacific Revenue Growth	6.29%	-3.77%

EBITDA

Financials in millions CHF. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013
Hearing Instruments Segment Operating Profit Before Acquisition-Related Amortization (EBITA)	729.60M	721.40M	701.70M
Hearing Instruments Segment Operating Profit Before Acquisition-Related Amortization (EBITA) Growth	1.14%	2.81%	-9.04%
Cochlear Implants Segment Operating Profit Before Acquisition-Related Amortization (EBITA)	-700.00K	28.40M	25.40M
Cochlear Implants Segment Operating Profit Before Acquisition-Related Amortization (EBITA) Growth	-	11.81%	-15.62%

Key Performance Indicators

Financials in millions CHF. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013
Hearing Instruments Business Growth in Local Currencies	8.50%	0.70%
Audiological Care Business Growth in Local Currencies	6.40%	9.20%
Consumer Hearing Business Growth in Local Currencies	6.40%	-9.30%
Total Hearing Instruments Segment Growth in Local Currencies	7.50%	3.20%
Cochlear Implant Systems Growth in Local Currencies	16.30%	6.80%
Upgrades and Accessories Growth in Local Currencies	-3.90%	-2.10%
Total Cochlear Implants Segment Growth in Local Currencies	9.50%	3.60%

Updated Sep 30, 2025. Data Source: Fiscal.ai.